Suppr超能文献

HIV-1变异会降低CD4 T淋巴细胞的识别能力。

HIV-1 variation diminishes CD4 T lymphocyte recognition.

作者信息

Harcourt G C, Garrard S, Davenport M P, Edwards A, Phillips R E

机构信息

Molecular Immunology Group, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom.

出版信息

J Exp Med. 1998 Nov 16;188(10):1785-93. doi: 10.1084/jem.188.10.1785.

Abstract

Effective long-term antiviral immunity requires specific cytotoxic T lymphocytes and CD4(+) T lymphocyte help. Failure of these helper responses can be a principle cause of viral persistence. We sought evidence that variation in HIV-1 CD4(+) T helper epitopes might contribute to this phenomenon. To determine this, we assayed fresh peripheral blood mononuclear cells from 43 asymptomatic HIV-1(+) patients for proliferative responses to HIV-1 antigens. 12 (28%) showed a positive response, and we went on to map dominant epitopes in two individuals, to p24 Gag restricted by human histocompatibility leukocyte antigen (HLA)-DR1 and to p17 Gag restricted by HLA-DRB52c. Nine naturally occurring variants of the p24 Gag epitope were found in the proviral DNA of the individual in whom this response was detected. All variants bound to HLA-DR1, but three of these peptides failed to stimulate a CD4(+) T lymphocyte line which recognized the index sequence. Antigenic variation was also detected in the p17 Gag epitope; a dominant viral variant present in the patient was well recognized by a specific CD4(+) T lymphocyte line, whereas several natural mutants were not. Importantly, variants detected at both epitopes also failed to stimulate fresh uncultured cells while index peptide stimulated successfully. These results demonstrate that variant antigens arise in HIV-1(+) patients which fail to stimulate the T cell antigen receptor of HLA class II-restricted lymphocytes, although the peptide epitopes are capable of being presented on the cell surface. In HIV-1 infection, naturally occurring HLA class II-restricted altered peptide ligands that fail to stimulate the circulating T lymphocyte repertoire may curtail helper responses at sites where variant viruses predominate.

摘要

有效的长期抗病毒免疫需要特异性细胞毒性T淋巴细胞和CD4(+) T淋巴细胞辅助。这些辅助反应的失败可能是病毒持续存在的主要原因。我们寻找证据表明HIV-1 CD4(+) T辅助表位的变异可能导致这种现象。为了确定这一点,我们检测了43名无症状HIV-1(+)患者的新鲜外周血单核细胞对HIV-1抗原的增殖反应。12名(28%)显示出阳性反应,我们接着在两名个体中绘制优势表位,针对受人类组织相容性白细胞抗原(HLA)-DR1限制的p24 Gag和受HLA-DRB52c限制的p17 Gag。在检测到这种反应的个体的前病毒DNA中发现了9种p24 Gag表位的天然变体。所有变体都与HLA-DR1结合,但其中三种肽未能刺激识别索引序列的CD4(+) T淋巴细胞系。在p17 Gag表位也检测到了抗原变异;患者体内存在的一种优势病毒变体被特定的CD4(+) T淋巴细胞系很好地识别,而几种天然突变体则未被识别。重要的是,在两个表位检测到的变体也未能刺激新鲜的未培养细胞,而索引肽则成功刺激了细胞。这些结果表明,HIV-1(+)患者中出现的变异抗原无法刺激HLA II类限制淋巴细胞的T细胞抗原受体,尽管肽表位能够呈递在细胞表面。在HIV-1感染中,天然存在的未能刺激循环T淋巴细胞库的HLA II类限制的改变肽配体可能会在变异病毒占主导的部位减少辅助反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644d/2212407/0cc6063b0d81/JEM980677.f1a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验